COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study
Background The UK COVID-19 vaccination programme has prioritised vaccination of those at the highest risk of COVID-19 mortality and hospitalisation. The programme was rolled out in Scotland during winter 2020–21, when SARS-CoV-2 infection rates were at their highest since the pandemic started, despi...
Main Authors: | Agrawal, U, Katikireddi, SV, McCowan, C, Mulholland, RH, Azcoaga-Lorenzo, A, Amele, S, Fagbamigbe, AF, Vasileiou, E, Grange, Z, Shi, T, Kerr, S, Moore, E, Murray, JLK, Shah, SA, Ritchie, L, O'Reilly, D, Stock, SJ, Beggs, J, Chuter, A, Torabi, F, Akbari, A, Bedston, S, McMenamin, J, Wood, R, Tang, RSM, de Lusignan, S, Hobbs, FDR, Woolhouse, M, Simpson, CR, Robertson, C, Sheikh, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2021
|
Similar Items
-
First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
by: Simpson, CR, et al.
Published: (2021) -
First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: a pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales
by: Kerr, S, et al.
Published: (2022) -
Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
by: Simpson, CR, et al.
Published: (2022) -
BNT162b2 and ChAdOx1 nCoV-19 vaccine effectiveness against death from the delta variant
by: Sheikh, A, et al.
Published: (2021) -
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
by: Vasileiou, E, et al.
Published: (2021)